Phibro Animal Health (PAHC) Common Equity (2013 - 2026)
Phibro Animal Health (PAHC) posted quarterly Common Equity of $361.8 million for Q1 2026, up 36.03% year-over-year from $266.0 million in Q1 2025, and up 8.87% quarter-over-quarter from $332.4 million in Q4 2025.
Phibro Animal Health (PAHC) Common Equity (2013 - 2026) Analysis & Trends
Phibro Animal Health's Common Equity history runs 14 years deep, the most recent figure standing at $361.8 million for Q1 2026.
- In Q1 2026, Common Equity rose 36.03% year-over-year to $361.8 million; the TTM figure through Mar 2026 stood at $361.8 million (up 36.03% YoY), while the FY2025 annual figure was $285.7 million, up 11.32% from the prior year.
- Common Equity for Q1 2026 stood at $361.8 million, up from $332.4 million in the prior quarter.
- The five-year high for Common Equity was $361.8 million in Q1 2026, with the low at $246.8 million in Q4 2024.
- The 5-year median for Common Equity is $270.1 million (2024), against an average of $279.3 million.
- The sharpest annual moves came in 2024 and 2026: Common Equity slipped 9.16% in 2024, then soared 36.03% in 2026.
- Phibro Animal Health's Common Equity stood at $268.4 million in 2022, then advanced by 0.91% to $270.8 million in 2023, then fell by 8.86% to $246.8 million in 2024, then surged by 34.67% to $332.4 million in 2025, then climbed by 8.87% to $361.8 million in 2026.
- Business Quant data shows PAHC's Common Equity at $361.8 million in Q1 2026, $332.4 million in Q4 2025, and $311.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 4.05 Bn |
| 10 | Phibro Animal Health | 1.42 Bn | 1.35 Bn | 125.68 Mn | 361.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 361.83 Mn |
| Dec 31, 2025 | 332.36 Mn |
| Sep 30, 2025 | 311.68 Mn |
| Jun 30, 2025 | 285.68 Mn |
| Mar 31, 2025 | 265.99 Mn |
| Dec 31, 2024 | 246.80 Mn |
| Sep 30, 2024 | 258.53 Mn |
| Jun 30, 2024 | 256.64 Mn |
| Mar 31, 2024 | 270.09 Mn |
| Dec 31, 2023 | 270.80 Mn |
| Sep 30, 2023 | 273.07 Mn |
| Jun 30, 2023 | 282.51 Mn |
| Mar 31, 2023 | 272.33 Mn |
| Dec 31, 2022 | 268.37 Mn |
| Sep 30, 2022 | 262.76 Mn |
| Jun 30, 2022 | 262.44 Mn |
| Mar 31, 2022 | 266.95 Mn |
| Dec 31, 2021 | 239.29 Mn |
| Sep 30, 2021 | 233.31 Mn |
| Jun 30, 2021 | 238.53 Mn |